Tulane University President Michael A. Fitts remembers the first time he saw the former Charity Hospital building in downtown New Orleans.
The mammoth limestone structure stood gray and silent. Its darkened windows emitted no light, nor gave any clue as to what this mighty edifice had once meant to generations of New Orleanians who had been born there, cared for there or said goodbye to a loved one there. From the building’s leaf-strewn approach to the apex of its 20th floor, there was no hint of its role beyond serving as a vestige of a bygone era, a sentinel of a shuttered past. Fitts, however, sensed something else in the gray stillness. Hope.
With the right plan, the right vision and the right partners, Fitts knew that the former Charity Hospital building, with its 1 million square feet and location in the heart of the city’s burgeoning BioDistrict, could be the site of the most important and consequential redevelopment project in Tulane’s history and, perhaps, in the city itself.
“I grew up in West Philadelphia and I have seen, firsthand, what growth around a major research university, growth grounded in scientific discovery and medical breakthroughs, can do for a neighborhood and region,” Fitts said. “Startups and spinoffs based on a university’s intellectual property can improve lives through better treatments and cures while also creating a thriving community for residents.”
What Fitts envisions at 1532 Tulane Avenue is the creation of a true game changer that will reimagine one of the city’s most cherished buildings as a hub of scientific innovation while remaking the New Orleans economy into one centered on bioscience exploration and its breathtaking advancements. When Fitts announced this summer that Tulane had signed a purchase and sale agreement for the Charity project that would transition Tulane to an ownership role and main developer of the project, leaders at the city, state and federal levels cheered, while media from The Washington Post to the Times-Picayune hailed the effort.







































